Sergiy Revin

Diagnostics Research Laboratory (DRL) is the premier source for annotated human biospecimens and patient-derived tumor models. We are driven by cutting-edge science, and our mission is to accelerate the development of new treatments for cancer patients. Our Products WELL-CHARACTERIZED HUMAN BIO SAMPLES: We offer a wide range of well-characterized human biospecimens, including but not limited to frozen tissues, FFPE blocks, blood products, and other body fluids. PRIMARY CANCER CELLS: We also offer various primary cancer cells derived from tumors and surrounding healthy tissues. 3D CANCER MODELS: Cancer Spheroids. We offer 3D tumor models, such as cancer spheroids, which are powerful tools for studying cancer biology and drug discovery. Our Services Target testing and validation in human models: We help you validate your molecular targets using our available human models: cancer primary cells, 3D cancer models, and a variety of bio-banked disease-relevant patient materials. Drug discovery compound screening: We screen your library of tool compounds in a high-throughput fashion using established in our lab in vitro disease-relevant 3D tumor models – cancer spheroids and organoids. Phase 0 clinical testing in human patients: Our phase 0 clinical testing approach can de-risk phase 1 clinical studies by testing therapeutics in human subjects and trials are performed ethically and legally in specific patient indications (such as patients with brain death) whose organ systems involving absorption, metabolism, and excretion perform normally, allowing investigational drugs to be tested in a relevant clinical setting prior to phase 1 testing. Why Choose DRL? At DRL, we are committed to providing our customers with the highest quality products and services. Contact us today to learn how we can help you accelerate your drug discovery process and develop new treatments for patients.